Evidence map›Paper›PMID 35717457›Full record

ArticleJournal of perinatology : official journal of the California Perinatal Association2022

Short and long-term outcomes of children with autoimmune congenital heart block treated with a combined maternal-neonatal therapy. A comparison study.

Amelia Ruffatti, Alessia Cerutti, Marta Tonello, Maria Favaro, Teresa Del Ross, Antonia Calligaro, Chiara Grava, Margherita Zen, Ariela Hoxha, Giovanni Di Salvo

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of perinatology : official journal of the California Perinatal Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 2 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Amelia RuffattiDepartment of Medicine, DIMED, University of Padua, Padua, Italy. amelia.ruffatti@unipd.it.ORCID http://orcid.org/0000-0003-1391-9828
Alessia CeruttiDepartment of Women's and Children's Health, Pediatric Cardiology Unit, University of Padua, Padua, Italy.
Marta TonelloDepartment of Medicine, DIMED, Rheumatology Unit, University of Padua, Padua, Italy.ORCID http://orcid.org/0000-0001-9826-4079
Maria FavaroDepartment of Medicine, DIMED, Rheumatology Unit, University of Padua, Padua, Italy.
Teresa Del RossDepartment of Medicine, DIMED, Rheumatology Unit, University of Padua, Padua, Italy.
Antonia CalligaroDepartment of Medicine, DIMED, Rheumatology Unit, University of Padua, Padua, Italy.
Chiara GravaDepartment of Medicine, Rheumatology Unit, S. Martino Hospital, Belluno, Italy.
Margherita ZenDepartment of Medicine, DIMED, Rheumatology Unit, University of Padua, Padua, Italy.
Ariela HoxhaDepartment of Medicine, DIMED, General Internal Medicine Unit, University of Padua, Padua, Italy.
Giovanni Di SalvoDepartment of Women's and Children's Health, Pediatric Cardiology Unit, University of Padua, Padua, Italy.
University of Padua · ITCTO Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe short and long-term outcomes of children with anti-Ro/La-related congenital heart block treated with a combined maternal-neonatal therapy protocol were compared with those of controls treated with other therapies. STUDY

designSixteen mothers were treated during pregnancy with a therapy consisting of daily oral fluorinated steroids, weekly plasma exchange and fortnightly intravenous immunoglobulins and their neonates with intravenous immunoglobulins (study group); 19 mothers were treated with fluorinated steroids alone or associated to intravenous immunoglobulins or plasma exchange (control group).

resultThe combined-therapy children showed a significantly lower progression rate from 2nd to 3rd degree block at birth, a significant increase in heart rate at birth and a significantly lower number of pacemaker implants during post-natal follow-up with respect to those treated with the other therapies.

conclusionThe combined therapy produced better short and long term outcomes with respect to the other therapies studied.

Indexed as

Heart BlockImmunoglobulins, IntravenousBetamethasoneChildFemaleHumansInfant, NewbornPregnancySteroids, FluorinatedBetamethasoneImmunoglobulins, IntravenousSteroids, Fluorinated

Identifiers

PMID35717457
OpenAlexW4283068129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.